Applied Pharmaceutical Nanotechnology 2019

October 25, 2019

Pfizer

1 Portland Street

Cambridge, MA 02139 

 

 

Plenary Speakers for APN 2019

 

Greg Troiano, MSE, Vice President of Technology and Chief Engineer, Seer, Inc.

Biomolecular Biosensors for Health Monitoring and Disease Detection - An Update

     
 

Ulrich van Andrian, M.D., Ph.D. Mallinckrodt Professor of Immunopathology, Harvard Medical School

Title TBA

 

Confirmed Speakers for APN 2019

   

Zohreh Amoozgar, PhD, Post Doctoral Research Fellow, Harvard Medical School at Massachusetts General Hospital

Title TBA

     
   

Gilles Besin, PhD, Sr. Director, Immunology, Moderna Therapeutics

Accelerated Blood Clearance of Lipid Nanoparticles Entails a Biphasic Humoral Response of B-1 Followed by B-2 Lymphocyte to Distinct Antigenic Moieties

     
   

Zhaohua Richard Huang, PhD, Senior Director of Research and Development, L.E.A.F. Pharmaceuticals

Case Studies on CMC and Regulatory Challenges of Liposomal Drug Development

     
   

Clarice Hutchens, PhD, Senior Director, Pfizer

Title TBA

     
   

Hakho Lee, Ph.D., Associate Professor, Harvard Medical School 

Promise of Liquid Biopsy for Cancer Management

     
   

Christopher Locher, Ph.D., CEO and Founder, Versatope Therapeutics 

Membrane Vesicles for Vaccine and Therapeutic Delivery

     
 

Shiladitya Sengupta, Ph.D., Associate Professor of Medicine, Harvard Medical School and Assistant Professor of Health Sciences and Technology, MIT

Understanding Cancer Immune Interactions at the Nanoscale: Going beyond T cell immune checkpoints

     
   

Young-Ho Song, Pfizer 

 A Novel in situ Hydrophobic Ion Paring (HIP) Formulation Strategy for Clinical Product Selection of a Nanoparticle Drug Delivery System

     
   

Gokul Swaminathan, PhD, Associate Principal Scientist, Merck Exploratory Science Center, Merck Research Laboratories

Novel Immuno-Modulatory Lipid Nanoparticle Formulations for Vaccines and Immuno-Oncology Applications

     
   

Shraddha Thakkar, PhD, Principal Investigator, U.S. FDA

Title TBA

 

Proposed Sessions for 2019: 

Session I: Particle Technology : Early and Late Stage Technology

Session II: Impact of Biology and Immunology in Nanotechnology

Session III: Regulatory Aspects of Nanotechnology

 

 

 

Please Join our Linkedin Group

Sessions

Session I: Particle Technology : Early and Late Stage Technology

Session II: Impact of Biology and Immunology in Nanotechnology

Session III: Regulatory Aspects of Nanotechnology

Registration

Click here to register for the APN 2019 conference online.

APN 2019 will take place October 25, 2019 at:

Pfizer, Cambridge, MA

 

The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3

Updates

Sign Up Today!

Privacy Policy